logo

For the Inventor, By the Inventor

Vosselaar, Belgium

Marcel A Janssen

USPTO Granted Patents = 13

Average Co-Inventor Count = 3.2

ph-index = 4

Forward Citations = 35(Granted Patents)


Company Filing History:

goldMedal13 out of 2,078 
 
Janssen Pharmaceutica Nv
 patents

Years Active: 1977-1997

Loading Chart...
13 patents (USPTO):Explore Patents
1. 5604230 - Heterocycle-substituted benzenemethanamine derivatives (1997-02-18),
2. 5587387 - Heterocycle-substituted benzenemethanamine derivatives (1996-12-24),
3. 5552430 - Heterocycle-substituted benzenemethanamine derivatives (1996-09-03),
4. 5550135 - Heterocycle-substituted benzenemethanamine derivatives (1996-08-27),
5. 5541215 - Heterocycle-substituted benzenemethanamine derivatives (1996-07-30),
6. 5491161 - Pyrroloimidazolyl and imidazopyridinyl substituted 1H-benzimidazole (1996-02-13),
7. 5480997 - Pyridine-substituted benzenemethanamine derivatives (1996-01-02),
8. 5480912 - Method of treating HIV-1 with .alpha.-substituted benzenemethanamine (1996-01-02),
9. 5457102 - Pyrroloimidazolyl and imidazopyridinyl substituted 1H-benzimidazole (1995-10-10),
10. 5407961 - .alpha.-substituted benzenemethanamine derivatives and pharmaceutical use (1995-04-18),
11. 5066656 - Pharmacologically active (6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)- (1991-11-19),
12. 4210646 - Antimicrobial compositions containing 1-(aryloxyphenyl)piperazines (1980-07-01),
13. 4005218 - Antiparasitic salicylanilide derivatives (1977-01-25),

Title: Marcel A. Janssen: Innovator in Antiretroviral Compounds

Introduction

Marcel A. Janssen is a notable inventor based in Vosselaar, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiretroviral compounds. With a total of 13 patents to his name, Janssen's work has the potential to impact the treatment of viral infections, including HIV.

Latest Patents

One of his latest patents focuses on heterocycle-substituted benzenemethanamine derivatives. This invention is concerned with antiretroviral compounds that exhibit efficacy against HIV-1. The compounds are characterized by specific chemical formulas, where various substituents can be halo, methyl, hydrogen, nitro, or trifluoromethyl. Additionally, the patent outlines pharmaceutical compositions containing these compounds and the processes for their preparation.

Career Highlights

Marcel A. Janssen has built a distinguished career at Janssen Pharmaceutica NV, a leading pharmaceutical company. His innovative work in drug development has positioned him as a key figure in the fight against viral diseases. His extensive research and patent portfolio reflect his commitment to advancing medical science.

Collaborations

Throughout his career, Janssen has collaborated with esteemed colleagues, including Georges H. Van Daele and Jean-Paul R. Bosmans. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Marcel A. Janssen's contributions to the field of pharmaceuticals, particularly in antiretroviral compounds, underscore his role as a significant inventor. His work continues to pave the way for advancements in medical treatments, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…